$NXGL Income Statement | Understand Stock

$NXGL

$4.26 +$0.29 (7.45%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues, net
Cost of revenues
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Change in fair value of warrant liability
Forgiveness of debt
Debt discount costs
Other income (expense)
Change in fair value of warrant liability, net of warrant modification expense
Forgiveness of debt
Debt financing costs
Realized gain on investments in marketable securities
Loss on debt extinguishment
Total other income (expense)
Interest expense
Interest expense, net
Change in fair value of contingent consideration
Gain in spin-off of NexGelRx
Other expense
Other income
Total other income (expense), net

Loss before income taxes
Income Tax Expense (Benefit)
Net loss
Less: Loss attributable to non-controlling interest in joint venture
Net loss attributable to NexGel stockholders
Net loss per common share - basic
Net loss per common share - diluted
Weighted average shares used in computing net loss per common share - basic
Weighted average shares used in computing net loss per common share - diluted

Comments